Center for Vascular Disease
The Center for Vascular Disease is dedicated to providing comprehensive care to patients with vascular disease using the newest techniques for the prevention, diagnosis and treatment of circulatory problems. Our multidisciplinary approach strives to provide quality patient care, improve clinical outcomes, decrease complications and re-admission rates.
The Center for Vascular Disease is one of seven niche centers within Bluhm Cardiovascular Institute – a nationally recognized health care destination for those requiring highly specialized cardiovascular care.
What is vascular disease?
Vascular disease is an abnormal condition of the blood vessels, affecting nearly one out of two people in their lifetime, and can occur if your blood flow changes, becomes blocked or abruptly stops.
Vascular disease typically affects older individuals or those that:
- Have a family history of heart disease
- Have a history of smoking
- Are obese
- Have high cholesterol
- Have high blood pressure
Early detection of vascular disease is key
Identifying vascular disease in the early stages is key to improving long-term outcomes. The vascular laboratory provides advanced diagnostic tests seven days a week and is staffed by board-certified vascular surgeons and registered vascular technologists.
Meet the Teams
Vein Center
The Northwestern Medicine Vein Center offers multiple locations close to where you live and work. Board-certified interventional radiologists and vascular surgeons collaborate to provide you with the highest quality vein care.
Conditions
Treatments
- Carotid Endarterectomy
- Complementary and Supportive Therapy
- Endovenous Vein Ablation
- Medications for Heart and Vascular Disease
- Microphlebectomy
- Minimally Invasive Repair of the Aorta - Zenith Fenestrated AAA Endovascular Grafts
- Open Surgical Options for Aortic Dissection
- Risk Reduction for Heart and Vascular Disease
- Sclerotherapy
- Serial Testing
- Surgical Vein Ligation and Stripping
- Thrombectomy
- VBEAM
- VenaSeal
Vascular Disease Clinical Trials
Zfen+ The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.
Principal Investigator: Andrew Hoel, MD